STOCK TITAN

February 2025 Stock Gainers on News, Micro Caps Included

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of , 19 of 19 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest losers of February 2025 Every stock ranked by its February 2025 gain, with or without news

100

Ranked gains

+202.38%

Largest, MBRX

91.0%

Above baseline, day +5

29.2%

Median give-back, day +5

Filter and sort
Rows

100 ranked gains in February 2025

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rows are ordered by the move measured when the board was ranked. A percentage recomputed from the session's own closing prices can sit a little above or below its neighbours; the rank is the one the measured move gave the row.

Rank Symbol close to close Session Catalyst Announcement
1 MBRX under $25M today Also on the opposite board this month on both boards +202.38% against the close of 02/12/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Moleculin Receives Positive FDA Guidance for Acceleration of its Registration-Enabling MIRACLE Trial for R/R Acute Myeloid Leukemia (AML)

09:25 ET premarket

2 IVVD Also on the opposite board this month on both boards +196.34% against the close of 01/31/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Invivyd Announces Preliminary Fourth Quarter 2024 Financial Results, Strong Revenue Growth, and Reiterates Goal of Near-Term Profitability

06:55 ET premarket

3 AIFF under $25M today +170.97% against the close of 02/10/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Firefly Neuroscience Accepted into NVIDIA Connect Program

07:45 ET premarket

4 GCL +145.97% against the close of 02/14/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Reverse Merger / Shell UPDATE – GCL and RF Acquisition Corp. Complete Business Combination, GCL to Commence Trading on Nasdaq Under Ticker “GCL” and Announces Bell Ringing to Commemorate Listing

08:30 ET premarket

5 ATCH +136.60% against the close of 02/21/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement AtlasClear Holdings Releases Calendar Year End Numbers

17:41 ET after hours

6 XLO +125.27% against the close of 02/11/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies

07:30 ET premarket

7 NKGN under $25M today More than one ranked move this month 2+ ranked moves +121.64% against the close of 02/11/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory NKGen Biotech Receives U.S. FDA Fast Track Designation for Troculeucel for the Treatment of Moderate Alzheimer’s Disease

08:00 ET premarket

8 QNTM More than one ranked move this month 2+ ranked moves +111.01% against the close of 02/03/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial

07:03 ET premarket

9 ORGO +102.28% against the close of 02/27/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results

16:05 ET after hours

10 XOS +99.68% against the close of 02/19/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Xos, Inc. Announces Major Milestone: Xos Hub Listed on Federal GSA Schedule

16:00 ET after hours

11 AMOD under $25M today +96.74% against the close of 02/12/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Alpha Modus (Nasdaq: AMOD) Announces AI-Powered Retail Expansion with CashX—Targeting $75 Million in Annual Ad Revenue

08:50 ET premarket

12 APPS +96.46% against the close of 02/05/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Digital Turbine Reports Fiscal 2025 Third Quarter Financial Results

16:05 ET after hours

13 SRM +95.53% against the close of 02/13/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership SRM Entertainment Announces Lock-Up Agreement with Major Shareholder, Reinforcing Commitment to Long-Term Growth and Shareholder Value

08:30 ET premarket

14 LTRY More than one ranked move this month 2+ ranked moves +88.33% against the close of 02/03/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Lottery.com Inc. Announces Launch of International Lottery Operations

12:06 ET intraday

15 LIPO under $25M today More than one ranked move this month 2+ ranked moves +80.23% against the close of 02/05/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus

06:00 ET premarket

16 LTRY More than one ranked move this month 2+ ranked moves +78.23% against the close of 02/10/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Sports.com Enters Into Multi-Year Partnership Agreement With Soccerex

07:47 ET premarket

17 CPIX +76.53% against the close of 02/03/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Cumberland Pharmaceuticals Announces Breakthrough Results from the Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart Disease

07:30 ET premarket

18 EDSA +74.73% against the close of 02/12/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

07:00 ET premarket

19 PRCH release reads negative +74.14% against the close of 02/25/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Release reads negative, stock rose 74.14% Porch Group Reports Fourth Quarter 2024 Results

16:02 ET after hours

20 SINT under $25M today +70.92% against the close of 02/18/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

06:00 ET premarket

21 GHRS +69.72% against the close of 01/31/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results GH Research to Provide Update on Phase 2b Trial with GH001 in TRD

16:01 ET after hours

22 QNTM More than one ranked move this month 2+ ranked moves +69.00% against the close of 02/05/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Uplisting / Compliance Quantum Biopharma Licensee Celly Nutrition Retains Leading New York Investment Bank to Advise on Capital Raise and Possible Initial Public Offering Following Highly Positive Results from unbuzzd™ Clinical Study

07:30 ET premarket

23 PEPG +67.15% against the close of 02/21/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1

07:00 ET premarket

24 ULY under $25M today +60.50% against the close of 02/26/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Urgently Announces Capital Structure Improvements and Secures up to $20 Million in New Financing

17:00 ET after hours

25 WAFU under $25M today +59.22% against the close of 02/24/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Wah Fu Education Group Deeply Integrates DeepSeek: Driving AI-based Education Innovation and Establishing Long-term Growth Strategies

16:00 ET after hours

26 CYTH +54.55% against the close of 02/06/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Cyclo Therapeutics Presents Positive Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label Sub-Study in Patients (< 3 Years Old)

08:05 ET premarket

27 RENB +53.95% against the close of 02/25/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

13:25 ET intraday

28 SOAR under $25M today Also on the opposite board this month on both boards +49.25% against the close of 02/19/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Vaunt Surpasses $1.5M ARR in First Year, 100,000 Downloads, and 590 Flights—Fueling Unforgettable Travel Experiences

14:07 ET intraday

29 BREA +48.99% against the close of 02/24/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Brera Holdings Expands Commitment to Mozambique with Letter of Intent to Invest in Moçambola 2024 Champion Black Bulls, Elevating African talent to Global Platforms

17:00 ET after hours

30 GNS +48.44% against the close of 02/11/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Buyback / Dividend Genius Group calls EGM to approve share buyback, cancels rights offering.

08:00 ET premarket

31 NXU under $25M today +48.27% against the close of 02/11/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Nxu Announces Shareholder Approval of Merger with Verde Bioresins

06:20 ET premarket

32 GDEV +46.56% against the close of 02/20/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Buyback / Dividend GDEV Declares One-Time, Nonrecurring Special Cash Dividend of $3.31 Per Share

08:00 ET premarket

33 AUR +46.05% against the close of 02/12/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Aurora Announces Fourth Quarter 2024 Results

16:15 ET after hours

34 ACB +45.92% against the close of 02/04/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Aurora Cannabis Announces Fiscal 2025 Third Quarter Results

07:00 ET premarket

35 RNAZ More than one ranked move this month 2+ ranked moves +45.13% against the close of 02/04/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement TransCode Therapeutics, Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting

16:15 ET after hours

36 BBAI +44.81% against the close of 02/04/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership BigBear.ai Wins Department of Defense Contract to Prototype Near-Peer Adversary Geopolitical Risk Analysis for Chief Digital and Artificial Intelligence Office (CDAO)

09:15 ET premarket

37 ALLO +44.68% against the close of 02/13/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Allogene Therapeutics Announces Publication of Durable Response Data from Phase 1 ALPHA/ALPHA2 Trials of the Allogeneic CAR T Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma in the Journal of Clinical Oncology

16:30 ET after hours

38 BURU under $25M today +43.93% against the close of 02/20/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition NUBURU Opening New Frontiers: Strategic Acquisition to Drive Growth in Defense and Security Innovations

08:30 ET premarket

39 HLF +42.70% against the close of 02/19/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change catalyst from a later release the same session Herbalife Reports Q4 Net Sales at High End of Guidance, Q4 and Full-Year Net Sales Growth Excluding FX Headwinds¹; Q4 Adjusted EBITDA² Exceeds Guidance

16:10 ET after hours

40 LVTX +42.55% against the close of 02/24/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement LAVA Announces Evaluation of Strategic Options

07:00 ET premarket

41 LIPO under $25M today More than one ranked move this month 2+ ranked moves +41.64% against the close of 02/10/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus

05:46 ET premarket

42 OMI Also on the opposite board this month on both boards +39.04% against the close of 02/27/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Owens & Minor Reports Fourth Quarter & Full Year Financial Results and Announces Sale Process Underway for Products & Healthcare Services Segment

06:30 ET premarket

43 SUUN +38.31% against the close of 02/07/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings SolarBank Confirms Quarterly Financial Results Release Date and Earnings Call

08:00 ET premarket

44 FGEN +37.44% against the close of 02/19/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million

06:30 ET premarket

45 HCAI under $25M today +36.17% against the close of 02/06/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Uplisting / Compliance Huachen AI Parking Management Technology Holding Co., Ltd Announces Closing of Initial Public Offering

16:30 ET after hours

46 DOCS +35.99% against the close of 02/06/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Doximity Announces Fiscal 2025 Third Quarter Financial Results

16:01 ET after hours

47 ARBB under $25M today +35.83% against the close of 02/27/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership ARB IOT Group Limited Announces Entry Into a Memorandum of Understanding to Set-Up AI Data Centre Experimental Laboratory in the Region

16:00 ET after hours

48 LTBR +34.69% against the close of 02/11/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Lightbridge Successfully Co-Extrudes a Demonstration Coupon Sample with Uranium-Zirconium Alloy and Cladding

07:00 ET premarket

49 RRGB +34.51% against the close of 02/26/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Red Robin Gourmet Burgers, Inc. Reports Results for the Fiscal Fourth Quarter and Fiscal Year Ended December 29, 2024

16:05 ET after hours

50 AMSC +34.17% against the close of 02/05/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings AMSC Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Business Outlook

16:05 ET after hours

51 LDTC under $25M today +34.02% against the close of 01/31/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement LeddarTech Enters Into Amendments to Credit Facility and Bridge Financing Offer

07:00 ET premarket

52 TGI +33.94% against the close of 01/31/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition TRIUMPH to be Acquired by Affiliates of Warburg Pincus and Berkshire Partners in an All-Cash Transaction Valued at Approximately $3 Billion

05:00 ET premarket

53 GRAL +33.93% against the close of 02/12/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings GRAIL to Announce Fourth Quarter 2024 Financial Results

16:02 ET after hours

54 BRDG release reads negative +33.84% against the close of 02/21/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Release reads negative, stock rose 33.84% Bridge Investment Group Holdings Inc. Reports Fourth Quarter and Full Year 2024 Results

08:00 ET premarket

55 RILY +33.53% against the close of 02/21/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings B. Riley Financial to Report Preliminary Fourth Quarter 2024 Results and Host Update Call for Investors on Monday, March 3rd

06:00 ET premarket

56 LEU +33.13% against the close of 02/06/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Centrus Reports Fourth Quarter and Full Year 2024 Results

17:00 ET after hours

57 EQ +33.03% against the close of 02/05/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Equillium Announces Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative Colitis

08:00 ET premarket

58 MEG +32.63% against the close of 02/26/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Montrose Environmental Group Reports Record Fourth Quarter and Full Year 2024 Results and Provides Strong 2025 Guidance

16:30 ET after hours

59 CGBS +32.52% against the close of 02/14/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Crown LNG Signs Gas Sales MOU with India Gas Exchange

08:00 ET premarket

60 LUNG +32.23% against the close of 02/19/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results

16:05 ET after hours

61 PONY +32.05% against the close of 02/20/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Pony AI Inc. Becomes First to Offer Robotaxi Operations Connecting Guangzhou’s City Center to Key Transportation Hubs

04:00 ET premarket

62 UPST +31.82% against the close of 02/11/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Upstart Announces Fourth Quarter and Full Year 2024 Results

16:05 ET after hours

63 KTTA under $25M today +31.73% against the close of 02/04/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer

06:59 ET premarket

64 SLDB +31.51% against the close of 02/14/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003

06:45 ET premarket

65 AHT under $25M today +31.50% against the close of 02/12/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement ASHFORD HOSPITALITY TRUST ANNOUNCES FULL PAY OFF OF STRATEGIC FINANCING

16:16 ET after hours

66 GOTU +31.23% against the close of 02/25/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Gaotu Techedu Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

01:00 ET premarket

67 AIOT +31.09% against the close of 02/07/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Powerfleet Reports Third Quarter 2025 Financial Results

07:00 ET premarket

68 REBN under $25M today More than one ranked move this month 2+ ranked moves +30.95% against the close of 02/19/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Reborn Coffee Dubai Drives European Flagship Expansion into Vienna, Florence, And Prague

08:31 ET premarket

69 SLQT +30.82% against the close of 02/10/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings SelectQuote, Inc. Reports Second Quarter of Fiscal Year 2025 Results

16:05 ET after hours

70 FLXS +30.81% against the close of 02/03/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Flexsteel Industries, Inc. Reports Strong Fiscal Second Quarter 2025 Results

16:10 ET after hours

71 ANAB +30.51% against the close of 02/11/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Anaptys to Announce Top-line Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, in Rheumatoid Arthritis on Feb. 12, 2025

17:30 ET after hours

72 REBN under $25M today More than one ranked move this month 2+ ranked moves +30.42% against the close of 02/14/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Reborn Coffee Secures Commitments for 33 New Locations Through Strategic Franchise Area Development Partnerships Following Successful Seminar

08:31 ET premarket

73 U +30.41% against the close of 02/19/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Unity Reports Fourth Quarter and Fiscal Year 2024 Financial Results

07:55 ET premarket

74 VMAR under $25M today +29.82% against the close of 02/26/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Vision Marine Technologies Inc. Signs Global Exclusive Supply Agreement With STERK for Electric Boats

02:30 ET premarket

75 BROS +29.10% against the close of 02/12/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Dutch Bros Inc. Reports Fourth Quarter and Fiscal Year 2024 Financial Results

16:05 ET after hours

76 COMP +28.32% against the close of 02/18/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Compass, Inc. Reports Fourth Quarter and Full-Year 2024 Results

16:05 ET after hours

77 AVNW +28.22% against the close of 02/04/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Aviat Networks Announces Fiscal 2025 Second Quarter and Six Month Financial Results

16:05 ET after hours

78 UDMY +28.01% against the close of 02/13/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Udemy Reports Fourth Quarter and Full Year 2024 Results

16:05 ET after hours

79 CELH +27.77% against the close of 02/20/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Celsius Holdings to Acquire Alani Nu®, Creating a Leading Better-For-You, Functional Lifestyle Platform

16:30 ET after hours

80 RNAZ More than one ranked move this month release reads negative 2+ ranked moves +27.18% against the close of 02/05/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Release reads negative, stock rose 27.18% TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial

08:00 ET premarket

81 AMPS +27.15% against the close of 02/05/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Altus Power Announces Agreement to be Acquired by TPG

07:00 ET premarket

82 EVER +27.15% against the close of 02/24/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings EverQuote Announces Fourth Quarter and Full Year 2024 Financial Results

16:05 ET after hours

83 NKGN under $25M today More than one ranked move this month 2+ ranked moves +27.12% against the close of 02/20/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory NKGen Biotech Announces Administration of First Dose of Troculeucel to Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program

08:00 ET premarket

84 APTO under $25M today More than one ranked move this month 2+ ranked moves +27.04% against the close of 02/11/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Aptose’s Frontline Triple Drug Therapy with Tuspetinib Achieves Notable Responses in Newly Diagnosed AML Patients in the Phase 1/2 TUSCANY Trial

07:00 ET premarket

85 TUYA +26.80% against the close of 02/19/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Tuya Smart x DeepSeek: Multimodal AI Reshapes the Future of Pet Care

00:31 ET premarket

86 JG +26.79% against the close of 02/04/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Aurora Mobile’s GPTBots.ai Integrates DeepSeek’s Janus-Pro

05:00 ET premarket

87 ATEX +26.79% against the close of 02/10/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Anterix Announces Industry Engagement Initiative to Accelerate Private Wireless Broadband Opportunity and Engages Morgan Stanley to Initiate Strategic Review Process

07:00 ET premarket

88 APTO under $25M today More than one ranked move this month 2+ ranked moves +26.75% against the close of 02/19/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Aptose Announces Positive Clinical Safety Review Committee (CSRC) Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib Amid Complete Responses and Favorable Safety in First Cohort

07:32 ET premarket

89 TCX +26.57% against the close of 02/13/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Buyback / Dividend Tucows Announces $40 Million Stock Buyback Program

17:02 ET after hours

90 MNDY +26.46% against the close of 02/07/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings catalyst from a later release the same session monday.com Announces Full Release of monday service, its AI Enterprise Service Management Platform

07:00 ET premarket

91 COMM +26.18% against the close of 02/25/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings CommScope Reports Fourth Quarter and Full Year 2024 Results

06:30 ET premarket

92 CRSR +25.86% against the close of 02/12/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Corsair Gaming Reports Fourth Quarter and Full Year 2024 Financial Results

16:00 ET after hours

93 CTM +25.79% against the close of 02/24/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Castellum, Inc. Announces Its GTMR Subsidiary Has Been Selected as a SCI MAC Vendor

06:45 ET premarket

94 STIM +25.73% against the close of 02/07/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

16:30 ET after hours

95 ROOT +25.57% against the close of 02/26/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Root, Inc. Announces 2024 Fourth Quarter and Full Year Results

16:15 ET after hours

96 CFLT +25.08% against the close of 02/11/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Confluent and Databricks Partner to Usher In New Age of Real-Time AI

16:04 ET after hours

97 DDC under $25M today +25.00% against the close of 02/18/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement DDC Enterprise Provides 2024 Financial Guidance

08:30 ET premarket

98 PACB +25.00% against the close of 02/13/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial Results

16:05 ET after hours

99 MATH +24.87% against the close of 02/12/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Buyback / Dividend Metalpha Reports Half-Year FY2025 Financial Results with Revenues up Nearly Four-fold, and Announces a $5 Million Share Repurchase Program

08:35 ET premarket

100 ORGN under $25M today +24.76% against the close of 02/19/2025 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement In Historic First, Origin Materials Announces Commencement of PET Cap Commercial Production

07:00 ET premarket

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 226 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band

1 event was left out of this board because the measured session set no price of its own, trading either nothing at all or barely moving on an ordinary day's volume, so the figure it would be ranked on is a price carried onto the tape rather than a close.

1 event was left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In February 2025, the median gainer had given back 29.2% of its move five sessions later; the largest catalyst group was Earnings, 34 of the 100 events, at a median of +32.4%.

Close-to-close change on the measured trading session, against the previous close.

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst Events Share of board Median move close to close Median at day +5 Still above the pre-news close at day +5
Earnings 34 34.0% +32.4% +26.6% 97.1% of 34
Other Announcement 22 22.0% +34.4% +19.4% 81.8% of 22
Clinical Trial Results 13 13.0% +33.0% +31.3% 84.6% of 13
Contract / Partnership 10 10.0% +40.3% +16.3% 90.0% of 10
M&A / Acquisition 7 7.0% Fewer than 10 events in this group, so no figures are shown.

6 other catalyst types, 14 events: FDA & Regulatory, Buyback / Dividend, Offering / Dilution, Uplisting / Compliance, Reverse Merger / Shell, Leadership Change.

How much of the move survived

Horizon Still above the pre-news close close to close Median change since the measured close as a share of the move
Day +1 99.0% of 100 10.5% given back, of 100
Day +5 91.0% of 100 29.2% given back, of 100
Month end 75.3% of 97 65.0% given back, of 97
Month end falls before day +5 for 18 of these 97 events, so this row is not a later horizon than the one above it. 97 of the 100 events have a month-end close later than the measured session; 3 have it on the measured session itself.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside February 2025

Two or more ranked moves this month, each on a different trading day.

SymbolMeasured sessionsBest move
NKGN 2FDA & Regulatory +121.64%
QNTM 2Clinical Trial Results, Uplisting / Compliance +111.01%
LTRY 2Other Announcement, Contract / Partnership +88.33%
LIPO 2FDA & Regulatory, Clinical Trial Results +80.23%
RNAZ 2Other Announcement, Clinical Trial Results +45.13%
REBN 2Other Announcement, Contract / Partnership +30.95%
APTO 2Clinical Trial Results +27.04%

Also risen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

SymbolMonthsBest move
QUBT 2025-01, 2024-12, 2024-11 +92.75%
LAES 2025-01, 2024-12, 2024-11 +78.18%
CRNC 2025-01, 2024-11 +143.76%
AMODthis month too 2025-01, 2024-12 +103.90%
SPCB 2025-01, 2024-12 +59.34%
TDUP 2025-01, 2024-11 +58.50%
NUKK 2025-01, 2024-12 +754.68%
CYN 2025-01, 2024-12 +49.29%
TEM 2025-01, 2024-11 +35.53%
WKEY 2025-01, 2024-12 +139.02%
EVTL 2025-01, 2024-11 +45.51%
MVST 2025-01, 2024-11 +340.01%
GPUS 2025-01, 2024-12 +35.94%
PRCHthis month too 2024-12, 2024-11 +55.36%
RGTI 2024-12, 2024-11 +58.05%
KULR 2024-12, 2024-11 +77.49%
OMER 2024-12, 2024-11 +65.87%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

  • Pre-market58.0%
  • Intraday3.0%
  • After hours39.0%

Volume against normal

  • Under 5x9 events, 9.2%
  • 5x to 20x33 events, 33.7%
  • Over 20x56 events, 57.1%

2 events have too little trading history for a relative volume, and are not in the tiers above.

Industry

  • Pharmaceutical Preparations16 events, 16.0%
  • Services-prepackaged Software7 events, 7.0%
  • Biological Products, (no Disgnostic Substances)5 events, 5.0%
  • Biological Products, (no Diagnostic Substances)3 events, 3.0%
  • Retail-eating Places3 events, 3.0%
  • Surgical & Medical Instruments & Apparatus3 events, 3.0%

35 other industries, 41 events

Industry not known: 22.0%

3 events on this board carry the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against January 2025

100 events in the comparable window.

January 2025 median +40.3%, selected from the 8,657 events in that month's eligible pool

February 2025 median +34.1%, 6.2 points below January 2025. February 2025's median is taken over the 100 ranked rows, selected from the 9,679 events in that month's eligible pool.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

  • An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
  • One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
  • A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
  • No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.